Peña A S
Gastroenterology and Immunogenetics, VU University Medical Center, Amsterdam, The Netherlands.
Dig Dis. 2003;21(2):85-90. doi: 10.1159/000073241.
In this review, the evidence to support the multifactorial and polygenic nature of the disease is briefly described. The past of genetics of inflammatory bowel disease (IBD) is characterized by unfulfilled promises and is now closed with a new vision and a new promise coming from a genetic epidemiology approach. The genome-wide screening has led to the first gene of IBD and has given a new insight into the regulation of chronic inflammation. The future of IBD will be under scrutiny of the visionaries, but also the skeptics and the enthusiasts.
在本综述中,简要描述了支持该疾病多因素和多基因性质的证据。炎症性肠病(IBD)的遗传学过去充满了未实现的承诺,而现在随着遗传流行病学方法带来的新视野和新希望而告终。全基因组筛查已发现了IBD的首个基因,并为慢性炎症的调控提供了新的见解。IBD的未来将受到空想家、怀疑论者和热心者的审视。